<unk>  is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
Bimekizumab
Caplacizumab
Ixekizumab
Brolucizumab
Risankizumab
Satralizumab
Tocilizumab
Etaracizumab